Pb. Jeppesen et al., Stevioside acts directly on pancreatic beta cells to secrete insulin: Actions independent of cyclic adenosine monophosphate and adenosine triphosphate-sensitive K+-channel activity, METABOLISM, 49(2), 2000, pp. 208-214
The natural sweetener stevioside, which is found in the plant Stevia rebaud
iana Bertoni, has been used for many years in the treatment of diabetes amo
ng Indians in Paraguay and Brazil. However, the mechanism for the blood glu
cose-lowering effect remains unknown. To elucidate the impact of stevioside
and its aglucon steviol on insulin release from normal mouse islets and th
e beta-cell line INS-1 were used. Both stevioside and steviol (1 nmol/L to
1 mmol/L) dose-dependently enhanced insulin secretion from incubated mouse
islets in the presence of 16.7 mmol/L glucose (P < .05). The insulinotropic
effects of stevioside and steviol were critically dependent on the prevail
ing glucose concentration, ie, stevioside (1 mmol/L) and steviol (1 mu mol/
L) only potentiated insulin secretion at or above 8.3 mmol/L glucose (P < .
05), Interestingly, the insulinotropic effects of both stevioside and stevi
ol were preserved in the absence of extracellular Ca2+. During perifusion o
f islets, stevioside (1 mmol/L) and steviol (1 mu mol/L) had a long-lasting
and apparently reversible insulinotropic effect in the presence of 16.7 mm
ol/L glucose (P < .05). To determine if stevioside and steviol act directly
on beta cells, the effects on INS-1 cells were also investigated. Steviosi
de and steviol both potentiated insulin secretion from INS-1 cells (P < .05
), Neither stevioside (1 to 100 mu mol/L) nor steviol (10 nmol/L to 10 mu m
ol/L) influenced the plasma membrane K+ adenosine triphosphate (K-ATP(+))-s
ensitive channel activity, nor did they alter cyclic adenosine monophosphat
e (cAMP) levels in islets. In conclusion, stevioside and steviol stimulate
insulin secretion via a direct action on beta cells. The results indicate t
hat the compounds may have a potential role as antihyperglycemic agents in
the treatment of type 2 diabetes mellitus. Copyright (C) 2000 by W.B. Saund
ers Company.